Search results
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 2 days agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 4 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Emcure Pharma On The Way To D-Street Debut; IPO On July 3
Free Press Journal· 6 days agoThe Initial Public Offer of 'Emcure Pharmaceutical's will begin accepting subscriptions on July 3. A...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 4 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Did you know Rajkummar Rao's Shahid took 1.5 years for a 32-day shoot? Hansal Mehta's son recalls
Pinkvilla· 1 day agoMade on a budget of ₹65 lakh, Rajkummar Rao's critically acclaimed film, Shahid, is one of the best...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 3 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 5 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
When Rajkummar Rao’s Critically Acclaimed Shahid Took 1.5 Years For A 32-Day Shoot - News18
News18· 1 day agoFilmmaker Hansal Mehta left an impressive mark on the audience’s heart with his National...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 2 days agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP...
Livemint· 3 days agoEmcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new...